Exploring the Connection Between Metabolic-Associated Fatty Liver Disease and Thyroid Nodules: A Cross-Sectional Analysis in China - Scorecard - MDSpire

Exploring the Connection Between Metabolic-Associated Fatty Liver Disease and Thyroid Nodules: A Cross-Sectional Analysis in China

  • By

  • Jun Xiao

  • Shen Tian

  • Juan Wu

  • Zhou Xu

  • Hao Li

  • Shu Li

  • Xin-yu Liang

  • Yu-ling Chen

  • Vishnu Prasad Adhikari

  • Jing-yu Song

  • Chen-yu Ma

  • Rui-ling She

  • Zhao-xing Li

  • Liang Ran

  • Ling-quan Kong

  • March 6, 2026

  • 0 min

Share

Clinical Scorecard: Exploring the Connection Between Metabolic-Associated Fatty Liver Disease and Thyroid Nodules: A Cross-Sectional Analysis in China

At a Glance

CategoryDetail
Condition
Key MechanismsMAFLD is linked to metabolic abnormalities; TNs are assessed for malignancy risk using TI-RADS, which categorizes nodules based on specific ultrasound features.
Target Population
Care Setting

Key Highlights

  • additional_highlight

Guideline-Based Recommendations

Diagnosis

    Management

    • Focus on screening for MAFLD in patients with thyroid nodules, considering the latest evidence on the relationship between the two conditions.

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        78,077 participants from health examinations.

        Understanding the systemic impact of MAFLD is crucial for targeted interventions.

        Clinical Best Practices

        • add_rationale

        References

        Original Source(s)

        Exploring the Connection Between Metabolic-Associated Fatty Liver Disease and Thyroid Nodules: A Cross-Sectional Analysis in China

        • by Jun Xiao, Shen Tian, Juan Wu, Zhou Xu, Hao Li, Shu Li, Xin-yu Liang, Yu-ling Chen, Vishnu Prasad Adhikari, Jing-yu Song, Chen-yu Ma, Rui-ling She, Zhao-xing Li, Liang Ran, Ling-quan Kong

        • March 6, 2026

        Related Content

        Opposing gastric and jejunal regulation of CELA2A in obesity and after Roux-en-Y gastric bypass suggests a role in gastrointestinal metabolic signaling

        Addressing Tamoxifen-Associated Weight Gain: Lifestyle and Pharmacotherapy Options

        Tamoxifen is commonly prescribed in hormone receptor-positive breast cancer but also associated with weight gain, which can complicate survivorship care. This narrative review summarizes evidence on tamoxifen-associated weight gain and outlines pharmacologic weight management options in this population.

        Rural-Urban Disparities in Hepatocellular Carcinoma Incidence and Mortality